There have been 50 recent insider transactions recorded for Tempest Therapeutics, Inc. (TPST), including 46 buys and 3 sells. Total insider buying was valued at $16.6M and total insider selling at $989.93K.
Notable insiders with recent activity include Maestas Nicholas, Trojanowski Justin, Angel Matthew. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — TPST
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-31 |
Maestas Nicholas |
Chief Financial Officer |
RSU Award |
140,000 |
$1.64 |
$229.6K |
140,000 |
| 2026-03-31 |
Trojanowski Justin |
Corporate Controller |
RSU Award |
22,000 |
$1.64 |
$36.08K |
22,000 |
| 2026-03-24 |
Angel Matthew |
10 Percent Owner, Officer: CEO and President |
Informative Buy |
231,482 |
$2.16 |
$500K |
231,482 |
| 2026-02-04 |
Angel Matthew |
10 Percent Owner, Officer: CEO and President |
RSU Award |
269,621 |
$2.38 |
$641.7K |
269,621 |
| 2026-02-03 |
Angel Matthew |
10 Percent Owner, Officer: CEO and President |
Unknown |
- |
- |
- |
8,268,495 |
| 2026-01-27 |
Pellizzari Christine A |
Director |
RSU Award |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2026-01-27 |
Nichol Geoffrey |
Director |
RSU Award |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2026-01-27 |
Raab Michael |
Director |
RSU Award |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2026-01-27 |
Simantov Ronit |
Director |
RSU Award |
1,230 |
$2.94 |
$3.62K |
1,230 |
| 2025-01-02 |
Brady Stephen R |
President and CEO |
RSU Award |
550,000 |
$0.86 |
$473K |
550,000 |
| 2025-01-02 |
Whiting Samuel |
Chief Medical Officer |
RSU Award |
270,000 |
$0.86 |
$232.2K |
270,000 |
| 2025-01-02 |
Maestas Nicholas |
Chief Financial Officer |
RSU Award |
200,000 |
$0.86 |
$172K |
200,000 |
| 2025-01-02 |
Trojanowski Justin |
Corporate Controller |
RSU Award |
30,000 |
$0.86 |
$25.8K |
30,000 |
| 2024-08-12 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
Informative Sell |
387,999 |
$1.10 |
$426.99K |
209,941 |
| 2024-08-08 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
Informative Sell |
400,000 |
$1.35 |
$540.04K |
597,940 |
| 2024-07-03 |
Brady Stephen R |
President and CEO |
Informative Buy |
35,000 |
$2.11 |
$73.85K |
46,376 |
| 2024-07-02 |
Whiting Samuel |
Chief Medical Officer |
Informative Buy |
4,672 |
$2.13 |
$9.95K |
9,573 |
| 2024-06-28 |
Trojanowski Justin |
Corporate Controller |
Informative Buy |
7,500 |
$2.16 |
$16.2K |
22,168 |
| 2024-06-13 |
Pellizzari Christine A |
Director |
RSU Award |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-06-13 |
Nichol Geoffrey |
Director |
RSU Award |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-06-13 |
Raab Michael |
Director |
RSU Award |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-06-13 |
Simantov Ronit |
Director |
RSU Award |
16,000 |
$3.03 |
$48.48K |
16,000 |
| 2024-01-03 |
Brady Stephen R |
President and CEO |
RSU Award |
250,000 |
$4.66 |
$1.17M |
250,000 |
| 2024-01-03 |
Whiting Samuel |
Chief Medical Officer |
RSU Award |
100,000 |
$4.66 |
$466K |
100,000 |
| 2024-01-03 |
Maestas Nicholas |
VP of Strategy and Finance |
RSU Award |
40,000 |
$4.66 |
$186.4K |
40,000 |
| 2024-01-03 |
Trojanowski Justin |
Principal Accounting Officer |
RSU Award |
26,500 |
$4.66 |
$123.49K |
26,500 |
| 2023-10-11 |
Brady Stephen R |
President and CEO |
RSU Award |
725,000 |
$9.77 |
$7.08M |
725,000 |
| 2023-10-11 |
Whiting Samuel |
Chief Medical Officer |
RSU Award |
325,000 |
$9.77 |
$3.18M |
325,000 |
| 2023-10-11 |
Maestas Nicholas |
VP of Strategy and Finance |
RSU Award |
100,000 |
$9.77 |
$977K |
100,000 |
| 2023-10-11 |
Trojanowski Justin |
Corporate Controller |
RSU Award |
55,000 |
$9.77 |
$537.35K |
55,000 |
| 2023-06-15 |
Pellizzari Christine A |
Director |
RSU Award |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-06-15 |
Nichol Geoffrey |
Director |
RSU Award |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-06-15 |
Raab Michael |
Director |
RSU Award |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-06-15 |
Simantov Ronit |
Director |
RSU Award |
8,200 |
$1.42 |
$11.64K |
8,200 |
| 2023-01-03 |
Brady Stephen R |
Chief Executive Officer |
RSU Award |
177,300 |
- |
- |
177,300 |
| 2023-01-03 |
Dubensky Thomas W. |
President |
RSU Award |
102,700 |
- |
- |
102,700 |
| 2023-01-03 |
Whiting Samuel |
Chief Medical Officer |
RSU Award |
69,700 |
- |
- |
69,700 |
| 2023-01-03 |
Maestas Nicholas |
VP of Strategy and Finance |
RSU Award |
38,425 |
- |
- |
38,425 |
| 2023-01-03 |
Trojanowski Justin |
Corporate Controller |
RSU Award |
20,300 |
- |
- |
20,300 |
| 2022-10-03 |
Trojanowski Justin |
Corporate Controller |
RSU Award |
2,500 |
- |
- |
2,500 |
| 2022-09-30 |
Trojanowski Justin |
Corporate Controller |
Disposition |
10,000 |
$2.29 |
$22.9K |
- |
| 2022-06-22 |
Whiting Samuel |
Chief Medical Officer |
RSU Award |
55,680 |
- |
- |
55,680 |
| 2022-06-21 |
Brady Stephen R |
Chief Executive Officer |
RSU Award |
173,533 |
- |
- |
173,533 |
| 2022-06-21 |
Dubensky Thomas W. |
President |
RSU Award |
87,801 |
$2.35 |
$206.33K |
87,801 |
| 2022-06-21 |
Lorenzo Pierre |
Corporate Controller |
RSU Award |
8,477 |
- |
- |
8,477 |
| 2022-06-21 |
Maestas Nicholas |
VP of Strategy and Finance |
RSU Award |
51,270 |
- |
- |
51,270 |
| 2022-06-17 |
Pellizzari Christine A |
Director |
RSU Award |
3,500 |
- |
- |
3,500 |
| 2022-06-17 |
Nichol Geoffrey |
Director |
RSU Award |
3,500 |
$2.08 |
$7.28K |
3,500 |
| 2022-06-17 |
Raab Michael |
Director |
RSU Award |
3,500 |
- |
- |
3,500 |
| 2022-06-17 |
Woiwode Thomas |
Director |
RSU Award |
3,500 |
$2.08 |
$7.28K |
3,500 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
